Glen Kristiansen
Institute of Pathology
Charité University Hospital
Berlin
Germany
Name/email consistency: high
- Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times. Kristiansen, G., Jacob, J., Buckendahl, A.C., Grützmann, R., Alldinger, I., Sipos, B., Klöppel, G., Bahra, M., Langrehr, J.M., Neuhaus, P., Dietel, M., Pilarsky, C. Clin. Cancer Res. (2006)
- Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. Kristiansen, G., Pilarsky, C., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepcke, S., Dahl, E., Hinzmann, B., Specht, T., Pervan, J., Stephan, C., Loening, S., Dietel, M., Rosenthal, A. J. Pathol. (2005)
- CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Kristiansen, G., Pilarsky, C., Pervan, J., Stürzebecher, B., Stephan, C., Jung, K., Loening, S., Rosenthal, A., Dietel, M. Prostate (2004)
- ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Kristiansen, G., Pilarsky, C., Wissmann, C., Stephan, C., Weissbach, L., Loy, V., Loening, S., Dietel, M., Rosenthal, A. Prostate (2003)
- Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Kristiansen, G., Yu, Y., Schlüns, K., Sers, C., Dietel, M., Petersen, I. Anal. Cell. Pathol (2003)
- CD24 expression is a new prognostic marker in breast cancer. Kristiansen, G., Winzer, K.J., Mayordomo, E., Bellach, J., Schlüns, K., Denkert, C., Dahl, E., Pilarsky, C., Altevogt, P., Guski, H., Dietel, M. Clin. Cancer Res. (2003)
